Cafepharma Today

January 3 2025 - Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Lilly asks to join GLP-1 compounding lawsuit
Use of diabetes and anti-obesity drugs surges nationwide
How pharma was instrumental in President Jimmy Carter’s global health efforts
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Pfizer, Lilly among possible ImClone suitors
Fierce Pharma
Tuesday, September 30, 2008 - 8:55am
tags:
Enzon's New Oncaspar-IV(TM) Receives Orphan Drug Status in The EU
Trading Markets
Tuesday, September 30, 2008 - 8:54am
tags:
Drug stocks tumble after House votes down bailout
Marketwatch
Tuesday, September 30, 2008 - 8:53am
tags:
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
Yahoo
Tuesday, September 30, 2008 - 8:52am
tags:
Cardinal Health In Good Health
Forbes
Tuesday, September 30, 2008 - 8:24am
tags:
Pfizer's Change Of Heart
Forbes
Tuesday, September 30, 2008 - 8:21am
tags:
Pfizer To Abandon Heart Drugs: Report
The Street.com
Tuesday, September 30, 2008 - 8:15am
tags:
A.P. Pharma Announces Positive Phase 3 Results with APF530 in the Prevention of CINV
Yahoo
Tuesday, September 30, 2008 - 8:14am
tags:
Could Market Turmoil Foil Roche’s Bid for Genentech?
WSJ Online
Tuesday, September 30, 2008 - 8:14am
tags:
Under Sweeping Settlement, Cephalon Will Disclose Doctor Payments
WSJ Online
Tuesday, September 30, 2008 - 8:13am
tags:
Sanofi, Daiichi Delay Japan's First Imported Vaccine
Bloomberg
Tuesday, September 30, 2008 - 8:12am
tags:
Eli Lilly shares fall on uncertainty over FDA review of potential blockbuster blood-thinner
Yahoo/AP
Monday, September 29, 2008 - 12:20pm
tags:
4-Star Stocks Poised to Pop: Pfizer
Motley Fool
Monday, September 29, 2008 - 12:20pm
tags:
Osiris On Prochymal Commercialization
Cafepharma Detailpiece
Monday, September 29, 2008 - 12:19pm
tags:
Cephalon to pay $425 million to settle claims of marketing drugs for alternate uses
Yahoo/AP
Monday, September 29, 2008 - 11:17am
tags:
The Waiting Game Continues For Lilly & ImClone
CNBC
Monday, September 29, 2008 - 11:14am
tags:
Drug stocks slide as global markets swoon
Marketwatch
Monday, September 29, 2008 - 10:29am
tags:
Eli Lilly says Alimta gets regulatory approval as primary treatment for lung cancer
Yahoo/AP
Monday, September 29, 2008 - 10:29am
tags:
Regeneron Pharmaceuticals (REGN) Reports Results from Phase 2 Study of VEGF Trap-Eye
Street Insider
Monday, September 29, 2008 - 9:45am
tags:
ImClone says second acquirer set to bid or withdraw
Yahoo/Reuters
Monday, September 29, 2008 - 9:43am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Recipes Blogging: Kebab-e-Koobideh
In the Pipeline
Recipe Blogging: Varieties of Pickles
In the Pipeline
Targeted Cancer Drugs, Succeeding and Failing
In the Pipeline
Drugs Inside Cells - A Bit of Light
In the Pipeline
HPV Infections: Friend and Foe
In the Pipeline
Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes
Drug Channels
Ripping Through The Crystal
In the Pipeline
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun)
Drug Channels
Real High Throughput Chemistry Through Mass Spec
In the Pipeline

Latest Jobs

Vascular Consultant - 1719
League City, Texas, United States
FloodGate Medical
Clinical Specialist - $120K-$130K - Cardiovascular Space (Richmond, Charlottesville, Roanoke)
Roanoke, Virginia, United States
The Hoffman Group - Executive Recruiters
Associate Med device sales rep - diabetes
White Plains, New York, United States
DAVID BAGGA COMPANY
Specialty Account Manager - IVIG
Boston, Massachusetts, United States
CSI Pharmacy
Sales Representative, Iron Specialist, Women's Health - San Bernardino, CA
San Bernardino County, California, United States
RxSalesPros
Account Executive- Columbus
Columbus, Ohio, United States
CCS
Sales Representative, Iron Specialist, Women's Health - Sacramento, CA
Sacramento, California, United States
RxSalesPros
Territory Manager/ Pharmaceutical Sales Representative – Women’s Healthcare
Katy, Texas, United States
ImpactBio
Specialty Account Manager - IVIG
Charlotte, North Carolina, United States
CSI Pharmacy
Ophthalmology Pharmaceutical Sales Representative - Austin North Territory
Austin, Texas, United States
EVERSANA
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information